Education
About Us
Working with TipRanks
Follow Us
Conmed (CNMD)
NYSE:CNMD
Earnings Data
Report Date
Jul 23, 2025TBA Not Confirmed
Period Ending
2025 (Q2)Consensus EPS Forecast
1.12Last Year’s EPS
0.98Same Quarter Last Year
Moderate Buy
Based on 6 Analysts Ratings
Earnings Call Summary
Earnings Call Date:Apr 30, 2025
|% Change Since: 14.15%
|Next Earnings Date:Jul 23, 2025
Earnings Call Sentiment|Neutral
The earnings call reflects a mixed performance with strong revenue and earnings growth, improvement in key product segments, and positive cash flow management. However, supply chain challenges, international sales declines, and concerns over tariffs and currency impacts pose significant obstacles.Company Guidance
During CONMED's First Quarter Fiscal 2025 Earnings Conference Call, management provided updated financial guidance and insights into ongoing operational strategies. Total sales for the quarter reached $321.3 million, marking a 2.9% increase year-over-year, or 3.8% in constant currency, slightly surpassing initial guidance. Adjusted net income was reported at $29.6 million, a 19.6% increase from the previous year, with adjusted diluted earnings per share rising by 20.1% to $0.95. The company maintained its full-year constant currency growth guidance at 4% to 6%, adjusting the full-year revenue forecast to a range of $1.35 billion to $1.378 billion due to easing foreign exchange impacts. Adjusted EPS guidance was raised to $4.45 to $4.60, reflecting a currency-related improvement. Despite supply chain challenges, the company anticipates significant operational improvements and cost savings, expecting adjusted gross margins to remain relatively flat compared to 2024. The call also highlighted FDA clearance for a new BioBrace delivery device, promising further growth in orthopedics and surgical segments.Revenue Growth
Total sales for the quarter were $321.3 million, representing a year-over-year increase of 2.9% as reported and 3.8% in constant currency, which was better than the guidance provided.
Earnings Increase
Adjusted net income of $29.6 million increased 19.6% year-over-year and adjusted diluted net earnings per share of $0.95 increased 20.1% year-over-year.
Strong Performance in Key Segments
Orthopedics saw constant currency sales growth of 3.9%, led by double-digit sales growth in foot and ankle products and strong demand for BioBrace. General Surgery also grew 3.8%, driven by AirSeal and smoke evacuation with double-digit demand.
Supply Chain Improvement
Progress has been made in reducing the number of SKUs on backorder, with expectations to be in a better position by year-end.
Cash Flow and Debt Management
Cash flow from operations was $41.5 million compared to $29.1 million in the first quarter of 2024. Long-term debt decreased from $905.1 million at the end of 2024 to $891.4 million.
CNMD Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
CNMD Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Apr 30, 2025 | $49.11 | $57.19 | +16.45% |
Feb 05, 2025 | $73.75 | $67.13 | -8.98% |
Oct 30, 2024 | $64.85 | $67.81 | +4.56% |
Jul 31, 2024 | $68.42 | $64.76 | -5.35% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Conmed (CNMD) report earnings?
Conmed (CNMD) is schdueled to report earning on Jul 23, 2025, TBA Not Confirmed.
What is Conmed (CNMD) earnings time?
Conmed (CNMD) earnings time is at Jul 23, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is CNMD EPS forecast?
CNMD EPS forecast for the fiscal quarter 2025 (Q2) is 1.12.